Unsung Hwang
Medical · Detroit, MINPI 1932402864
Payments from drug & device makers
Across 200 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$671
- Amgen$578
- AstraZeneca$403
- Amarin Pharma, Inc.$307
- Ardelyx, Inc.$285
- Gilead$261
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,768100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 28 | $671 |
| Amgen | 24 | $578 |
| AstraZeneca | 19 | $403 |
| Amarin Pharma, Inc. | 13 | $307 |
| Ardelyx, Inc. | 12 | $285 |
| Gilead | 3 | $261 |
| Otsuka America Pharmaceutical, Inc. | 7 | $184 |
| Fresenius USA Marketing, Inc. | 9 | $176 |
| Lilly USA, LLC | 8 | $175 |
| Bayer | 8 | $166 |
| GSK | 8 | $164 |
| Calliditas Therapeutics US Inc. | 7 | $162 |
| Vivus LLC | 8 | $153 |
| AbbVie | 7 | $145 |
| Novartis | 4 | $131 |
| Nestle Healthcare Nutrition Inc. | 6 | $123 |
| Novo Nordisk | 5 | $102 |
| Ipsen Biopharmaceuticals, Inc | 1 | $98 |
| Merck | 4 | $81 |
| Sanofi | 3 | $72 |
| Ironwood Pharmaceuticals, Inc | 3 | $65 |
| Akebia Therapeutics Inc | 3 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Shield Therapeutics Inc | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Abbott | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,768 in reported general payments places this provider in the 85th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 226 | $189,756 |
| OzempicSemaglutide | 97 | $110,744 |
| JanuviaSitagliptin Phosphate | 94 | $75,990 |
| VascepaIcosapent Ethyl | 145 | $72,079 |
| TrulicityDulaglutide | 52 | $58,521 |
| CreonLipase/Protease/Amylase | 39 | $50,106 |
| ZenpepLipase/Protease/Amylase | 20 | $20,386 |
| FarxigaDapagliflozin Propanediol | 22 | $15,973 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,449 |
| TradjentaLinagliptin | 18 | $11,248 |
| MyrbetriqMirabegron | 19 | $9,478 |
| KerendiaFinerenone | 14 | $9,067 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $7,555 |
| Atorvastatin Calcium | 746 | $6,249 |
| Icosapent Ethyl | 24 | $6,069 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $671 | $201,004244 claims |
| Novo NordiskOzempic | $102 | $110,74497 claims |
| MerckJanuvia | $81 | $75,99094 claims |
| Lilly USA, LLCTrulicity | $175 | $58,52152 claims |
| AbbVieCreon | $145 | $50,10639 claims |
| AstraZenecaFarxiga | $403 | $15,97322 claims |
| GSKTrelegy Ellipta, Shingrix | $164 | $15,92840 claims |
| BayerKerendia | $166 | $9,06714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 755 medical providers in Michigan.
Other medical in Detroit
- John BrabantDetroit$26K
- Kimberly BelzerDetroit$16K
- Linda RyznarDetroit$16K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.